Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11094-021-02308-0 http://scihub22266oqcxt.onion/10.1007/s11094-021-02308-0 33456092!7797491!33456092     free     free     free       Pharm+Chem+J 2021 ; 54 (10): 989-996 Nephropedia Template TP {{tp|p=33456092|t=2021. COVID-19: Analysis of Drug Repositioning Practice |pdf=|usr=}}{{33456092}} gab.com Text COVID-19: Analysis of Drug Repositioning Practice JO: Pharm Chem J http://www.kidney.de/pget.php?&tw=1&pmid=33456092 #FOAvip An outbreak of a new coronavirus disease (COVID-19) in China in December 2019 became the epicenter for the spread of a global pandemic. The SARS-CoV-2 coronavirus causes a cascade of respiratory diseases similar to severe acute respiratory syndrome (SARS). Currently, there is no effective, specific, and safe treatment for COVID-19 to suppress the virus in the human body. The present study searched for pharmacological substances with antiviral activity for possible drug repositioning based on experimental and theoretical information in a series of publications on in vitro assays of agents against SARS-CoV-2. An analysis identified 46 well-known pharmaceutical substances that could be used for drug repositioning to create a therapy for COVID-19. Twit Text FOAVip COVID-19: Analysis of Drug Repositioning Practice ????Pharm Chem J http://www.kidney.de/pget.php?&tw=1&pmid=33456092 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33456092 #FOAvip English Wikipedia <ref>{{Cite pmid|33456092}}</ref> COVID-19: Analysis of Drug Repositioning Practice #MMPMID33456092 Savosina PI; Druzhilovskii DS; Poroikov VV Pharm Chem J 2021[]; 54 (10): 989-996 PMID33456092show ga An outbreak of a new coronavirus disease (COVID-19) in China in December 2019 became the epicenter for the spread of a global pandemic. The SARS-CoV-2 coronavirus causes a cascade of respiratory diseases similar to severe acute respiratory syndrome (SARS). Currently, there is no effective, specific, and safe treatment for COVID-19 to suppress the virus in the human body. The present study searched for pharmacological substances with antiviral activity for possible drug repositioning based on experimental and theoretical information in a series of publications on in vitro assays of agents against SARS-CoV-2. An analysis identified 46 well-known pharmaceutical substances that could be used for drug repositioning to create a therapy for COVID-19. äCOVID-19: Analysis of Drug Repositioning Practice (epmc).pdf DeepDyve Pubget Overpricing